Interesting Image

Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action
  • Majid Assadi
  • Seyed Javad Rekabpour
  • Abdullatif Amini
  • Habibollah Dadgar
  • Reza Nemati
  • Ali Gholamrezanezhad
  • Iraj Nabipour
  • Esmail Jafari
  • Hojjat Ahmadzadehfar
Mol Imaging Radionucl Ther 2021; 30: 107-109 DOI: 10.4274/mirt.galenos.2020.69783 PMID:34082512
Almost Complete Response with a Single Administration 225Ac-DOTATATE in a Patient with a Metastatic Neuroendocrine Tumor of Unknown Primary
  • Nalan Alan Selçuk
  • Emre Demirci
  • Meltem Ocak
  • Türkay Toklu
  • Selçuk Ergen
  • Levent Kabasakal
Mol Imaging Radionucl Ther 2022; 31: 139-141 DOI: 10.4274/mirt.galenos.2022.64497 PMID:35771003

Original Article

Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors
  • Emre Demirci
  • Nalan Alan Selçuk
  • Gamze Beydağı
  • Meltem Ocak
  • Türkay Toklu
  • Kaan Akçay
  • Levent Kabasakal
Mol Imaging Radionucl Ther 2023; 32: 226-232 DOI: 10.4274/mirt.galenos.2023.38258 PMID:37870290